Add BrightSurf on Google Email

Results of the INHALE-3 extension study: inhaled technosphere insulin plus insulin degludec in T1D

The INHALE-3 extension study found that a regimen of inhaled technosphere insulin and insulin degludec reduced post-meal hyperglycemia in adults with type 1 diabetes. The treatment showed significant improvements in mean time in range, with 43% of participants expressing interest in continuing the regimen.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalDiabetes Technology & Therapeutics·TypeRandomized controlled/clinical trial·DateMar 22, 2025

Extensive study on telemedicine for diabetes and coronary heart disease – Senior author concludes: "The hype around medical apps needs to be put into perspective"

A large study found that telemedicine and training apps had minimal positive effects on patients with type 2 diabetes and coronary heart disease. The study suggests that direct care from medical professionals remains crucial for improving health outcomes in this population.

SourceTechnical University of Munich (TUM)·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateFeb 12, 2025

Advanced wearable technology improves support for people with dementia and their caregivers

A new pilot study assesses how caregivers use advanced wearable technology to support people with dementia, finding that it reduces emotional strain and increases caregiver satisfaction. The technology, called Theora Care, provides a wearable device and smartphone application that alerts caregivers when the person has wandered.

SourceTexas A&M University·JournalJournal of Alzheimer’s Disease·DateFeb 3, 2025

CAMP 2.0 helps patients with contact dermatitis identify personal care products free of their allergens

The new CAMP 2.0 tool provides personalized medicine for managing allergic contact dermatitis by generating safe lists based on individual patch testing results. It offers thousands of product options and interactive tools to help patients find safe products, track their quality of life, and understand their allergens.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalDermatitis·TypeContent analysis·DateNov 12, 2024

Unique multidomain enzymes from bacteria

Researchers have identified a unique multidomain enzyme capable of catalysing two separate reactions, cyclization and hydroxylation, on a single peptide substrate. This breakthrough discovery opens the possibility of developing innovative drug molecules with potential therapeutic applications for life-threatening infections and cancer.

SourceNational University of Singapore·JournalNature Chemistry·DateOct 28, 2024

Benzoyl peroxide acne drugs lack stability and degrade into carcinogenic benzene including when kept at room temperature, new study

A new study found that benzoyl peroxide acne treatments lack stability and degrade into carcinogenic benzene when exposed to heat, UV light, or stored at room temperature. Refrigeration may be a practical solution to minimize unnecessary exposure until safer formulations are developed.

SourceElsevier·JournalJournal of Investigative Dermatology·TypeExperimental study·DateOct 7, 2024

Early release from NEJM Evidence

Researchers have developed a new treatment for deep diabetic foot ulcers, using intact fish skin grafts to promote healing. The study found that this innovative approach showed promising results in improving wound closure and reducing infection rates.

SourceNEJM Group·JournalNEJM Evidence·DateOct 4, 2024

Analysis finds cardiac devices recalled for safety reasons infrequently subjected to premarket or postmarket testing

A cross-sectional study of cardiovascular devices found that most recalled devices did not undergo clinical testing before authorization and were not required to undergo postmarket surveillance studies. The study highlights the need for more rigorous testing and monitoring of these devices to ensure patient safety.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateSep 16, 2024

Three top ways to stop smoking

A major new review of evidence has identified three top ways to stop smoking: combining behaviour support with medication like bupropion or nicotine replacement therapy. The Cochrane Tobacco Addiction Group's systematic reviews also found strong evidence for behavioural counselling and financial incentives.

SourceSociety for the Study of Addiction·JournalAddiction·TypeSystematic review·DateSep 4, 2024

Pharmacy naloxone standing order distribution may have reduced opioid fatality rates in Massachusetts

A new study found that communities with pharmacies implementing a state standing order to distribute naloxone without a prescription showed a significant decrease in opioid-related deaths. The analysis, conducted from 2013 to 2018, observed a gradual decline of 16% per year in cities with naloxone distribution, compared to those without.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateAug 29, 2024

Pharmacy naloxone standing order distribution may have reduced opioid fatality rates in Massachusetts

A new study found that communities with pharmacies dispensing standing order naloxone experienced a gradual and significant decrease in opioid deaths, averaging 16% per year. This suggests that expanding access to naloxone through state-mandated standing orders can save lives and reduce opioid fatality rates.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateAug 29, 2024

Strengthening global regulatory capacity for equitable access to vaccines in public health emergencies

Global regulatory bodies, particularly in low- and middle-income countries, need enhanced capacity to ensure timely and safe access to essential medical products. Experts suggest expanding regulatory pathways to prioritize public health by enabling faster reach of diagnostics, therapeutics, and vaccines.

SourceGeorgetown University Medical Center·JournalNew England Journal of Medicine·TypeCommentary/editorial·DateAug 3, 2024

Talking about a taboo

Researchers investigated how stigma affects women's menstrual health practices in Bangladesh. A study on group discussions found that normalizing the topic of menstruation empowers women to access better menstrual products. Women were willing to pay more for pads and showed increased interest in alternative products after open discussi...

SourceLudwig-Maximilians-Universität München·JournalJournal of Development Economics·DateMay 29, 2024

The effect of combinations of antibiotics and natural products on the antimicrobial resistance of Staphylococcus aureus and Pseudomonas aeruginosa

Researchers tested seven antibiotics in combination with various natural compounds, finding synergistic effects against multidrug-resistant bacteria. The study suggests combining antibiotics with plant extracts or phytochemicals could be a promising strategy to combat antimicrobial resistance.

SourceBentham Science Publishers·JournalThe Open Infectious Diseases Journal·DateMay 27, 2024

AI designs new drugs based on protein structures

Researchers at ETH Zurich have developed an AI algorithm that can design new active pharmaceutical ingredients by analyzing protein structures. The algorithm generates blueprints for potential drug molecules that increase or inhibit protein activity, reducing the need for lengthy discovery processes and minimizing side effects.

SourceETH Zurich·JournalNature Communications·DateApr 24, 2024

Trends in phenylephrine and pseudoephedrine sales

Despite a lack of clinical efficacy evidence, phenylephrine remained the most common oral decongestant in the US from 2012-2021, with hundreds of millions of units sold annually. Most phenylephrine products were co-formulated with antihistamines or antitussives, providing symptom relief for cough and cold symptoms.

SourceJAMA Network·JournalJAMA·DateFeb 8, 2024

Revealing the landscape of software as a medical device industry

The study reveals a diverse landscape of software as a medical device (SaMD) with notable progress in artificial intelligence/machine learning-based devices, accounting for 22% of all FDA-approved SaMDs. Established companies focus on incremental innovations, while new entrants and start-ups drive disruptive innovation.

SourceTokyo Institute of Technology·JournalJournal of Medical Internet Research·TypeData/statistical analysis·DateDec 7, 2023

Human insulin less temperature-sensitive than previously thought

A new Cochrane review has found that human insulin can be stored at room temperature for up to six months without losing potency. This breakthrough research offers hope to millions of people living with diabetes in low- and middle-income countries, particularly those with limited access to refrigeration or healthcare.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateNov 2, 2023

Finding the right doctor: can online rating platforms direct patients to higher-quality physicians?

A new study finds that online physician rating platforms can help disseminate important quality information to patients and direct them to higher-quality physicians. The research examines the impact of user-generated online ratings on healthcare choices and highlights their positive association with conventional measurements of physici...

SourceAmerican Marketing Association·JournalJournal of Marketing·DateJan 18, 2023

C-path to lead pre-consortium aimed at transforming, accelerating medical product development in alpha-1 antitrypsin deficiency

The Critical Path Institute has launched a pre-consortium collaboration with the FDA's CBER and CDER to accelerate medical product development in alpha-1 antitrypsin deficiency. The collaboration aims to define unmet needs in drug development and lay the groundwork for specific solutions.

SourceCritical Path Institute (C-Path)·TypeData/statistical analysis·DateOct 6, 2022

C-Path awarded FDA grant to establish public-private partnership to advance treatments for rare neurodegenerative diseases

The Critical Path Institute (C-Path) has established a public-private partnership with the FDA and NIH to advance treatments for rare neurodegenerative diseases. The partnership will leverage C-Path's expertise in data management, quantitative analytics, and regulatory science to accelerate medical product development.

C-Path and the European Joint Programme on Rare Diseases to expand global impact and partnership

The collaboration aims to create an interoperable global data ecosystem for rare diseases, accelerating the development of new therapies. This partnership benefits patients, regulators, advocacy stakeholders, researchers, and industry, while expanding C-Path's global capabilities in collaborating on methodologies and technologies.

SourceCritical Path Institute (C-Path)·TypeData/statistical analysis·DateFeb 1, 2022

Study on over a million people shows breakthrough COVID-19 infections occur more often and are more severe in immunocompromised

A large-scale study of over 1.2 million people found breakthrough COVID-19 infections are rare but more frequent and severe in those with weakened immune systems. The study supports the introduction of a third vaccine dose for immunocompromised individuals to increase protection.

SourceTaylor & Francis Group·JournalJournal of Medical Economics·TypeObservational study·DateNov 30, 2021

Most PPE not designed for ethnic minority health workers and women, study finds

A new study found that most personal protective equipment (PPE) masks are not designed for Black And Minority Ethnic (BAME) backgrounds and women, leading to inadequate protection. The research highlights the need for further studies on PPE development to account for differences in facial dimensions across gender and ethnicity.

SourceUniversity of Southampton·JournalBMJ Global Health·TypeMeta-analysis·DateNov 12, 2021